Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

• Κύριοι συγγραφείς: Xavier Sáez-Llorens (Συγγραφέας), Johnny Beltran-Rodriguez (Συγγραφέας), Jose M. Novoa Pizarro (Συγγραφέας), Ilhem Mensi (Συγγραφέας), Pavitra Keshavan (Συγγραφέας), Daniela Toneatto (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Taylor & Francis Group, 2018-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...